Report Categories
View AllRecent Articles
View All
The real story behind BlackRock Res BCX valuation Modest Decline 20260508
The quiet positioning of Clover Health CLOV nobody discusses Overhead Buying 20260508
OKUR OnKure Therapeutics reports narrower Q4 2025 loss than estimates shares drop 204 percent in trading
STN Stantec notches narrow Q4 2025 earnings beat as its stock dips slightly in todays trading
MGTX Q1 2026 Earnings WiderthanExpected Loss Despite Positive Stock Reaction
PSEC Q1 2026 Earnings EPS Misses Estimates as Investment Income Falls Short
CLIR Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Challenges
Community Bancorp CMTV Q4 2025 Earnings Solid EPS Performance Amid Steep Market Backlash
TCBK Q1 2026 Earnings Earnings Beat Estimates Amid Solid Operational Performance
Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377